Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR donors give a record £12m for cancer research
This year's donations income smashes last year’s achievement by more than £3 million.
ICR welcomes olaparib approval by European Medicines Agency
The European Medicines Agency has approved olaparib for women with ovarian cancer who have a BRCA1 or BRCA2 mutation.
Scientists map out how childhood brain tumours relapse
Researchers have discovered the unique genetic paths that the childhood brain tumour medulloblastoma follows when the disease comes back.
Boris Johnson hails ICR as ‘creative powerhouse’ as it tops university table
Mayor of London Boris Johnson hailed the ICR as a ‘creative powerhouse’, after it was ranked top in the Government’s Research Excellence Framework.
Mayor of London visits The Institute of Cancer Research
Mayor of London Boris Johnson visited the ICR today to hear about plans to create one of the world’s top centres for cancer drug discovery and life sciences.
ICR tops league table of university excellence
The ICR is the top higher education institution in the country in the overall league table of academic performance, the Government’s Research Excellence Framework has revealed.
Scientists use 3D printing to make replica organs for enhanced radiotherapy
ICR researchers have used 3D printing to produce replica models of tumours and organs of patients with cancer, to help calculate precisely how much radiation has been delivered to the cancer.
Combination therapy could be effective against resistant childhood cancer
Using two targeted drugs at once could be an effective treatment strategy for children with an aggressive form of cancer who develop resistance to a single targeted drug, a new study shows.
Major trial finds better treatment for some women with familial and triple negative breast cancer
Initial results from a major phase III clinical trial reveal that women with a type of breast cancer are much more likely to respond to chemotherapy drug carboplatin than standard treatment.
New targeted drugs could treat drug-resistant skin cancer
A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports.
Celebrities support cancer research at ICR’s ‘Carols from Chelsea’
More than 400 people attended the sold-out event on Tuesday night which was hosted by the ICR in the beautiful Wren Chapel of the Royal Hospital, Chelsea.
Test assesses whether immune system is holding cancer in check
ICR scientists have developed a new high-tech system for measuring the body’s immune response to cancer: that combines computerised imaging of tumour samples with statistical analysis, and is the first objective method to measure the interaction between a patient’s immune system and their tumour.